2025
SJR Q2
JCR Q2 · 3,5
OA
5 eşleşen makale
SCIE
Dergi ayrıntısı
Innate Immunity
- Yayıncı
- SAGE Publications Ltd
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
1753425917534267
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,926
- Quartile Q2
- H-Index 84
- Atıf/yayın 3,77
- Doküman (3y) 50
- Atıf (3y) 191
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,5
- 5Y JIF 3,4
- JCI 0,59
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Cell Biology Q3
- Immunology Q2
- Infectious Diseases Q2
- Microbiology Q2
- Molecular Biology Q2
Alanlar
- Biochemistry, Genetics and Molecular Biology
- Immunology and Microbiology
- Medicine
WoS kategorileri
- Biochemistry & Molecular Biology | Immunology | Medicine, Research & Experimental | Microbiology
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,926 | 3,5 | 3,4 | 0,59 | Q2 | 84 |
| 2024 | Q2 | Q2 | 0,917 | 2,8 | 2,9 | 0,59 | Q3 | 81 |
| 2023 | Q2 | Q2 | 0,76 | 2,8 | 3,1 | 0,57 | Q3 | 81 |
| 2022 | Q2 | Q3 | 0,657 | 3,2 | 3,1 | 0,5 | Q3 | 81 |
| 2021 | Q2 | Q3 | 0,644 | 3 | 3,4 | 0,49 | Q3 | 81 |
| 2020 | Q2 | Q3 | 0,921 | 2,7 | 2,9 | 0,59 | Q3 | 81 |
| 2019 | Q2 | Q3 | 0,91 | 2,3 | 2,3 | 0,66 | Q3 | 81 |
| 2018 | — | Q3 | — | 2,2 | 2,5 | 0,69 | Q2 | — |
| 2017 | Q2 | Q3 | 1,031 | 2,3 | 2,4 | 0,78 | Q2 | 81 |
| 2016 | Q2 | Q3 | 1,169 | 2,3 | 2,4 | — | — | 81 |
| 2015 | Q2 | Q2 | 1,264 | 2,8 | 2,7 | — | — | 81 |
| 2014 | Q1 | Q2 | 1,275 | 3,3 | 3 | — | — | 81 |
| 2013 | Q2 | Q2 | 1,146 | 2,5 | 2,7 | — | — | 81 |
| 2012 | Q2 | Q2 | 1,086 | 2,7 | 3 | — | — | 81 |
| 2011 | Q2 | Q1 | 1,151 | 4 | 3,7 | — | — | 81 |
| 2010 | Q2 | Q2 | 0,931 | 3,3 | 3,3 | — | — | 81 |
| 2009 | — | Q2 | — | 2,2 | 2,2 | — | — | — |
| 2008 | — | — | — | — | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 163/328 |
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q3 | 89/183 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q2 | 82/191 |
| 2025 | MICROBIOLOGY | SCIE | Q2 | Q3 | 82/167 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 187/320 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q3 | 107/183 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 96/195 |
| 2024 | MICROBIOLOGY | SCIE | Q3 | Q3 | 89/163 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 184/313 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 118/181 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 92/189 |
| 2023 | MICROBIOLOGY | SCIE | Q3 | Q3 | 85/161 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 169/285 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q3 | 110/161 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 84/136 |
| 2022 | MICROBIOLOGY | SCIE | Q3 | Q3 | 75/135 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 219/297 |
| 2021 | IMMUNOLOGY | SCIE | Q4 | Q3 | 132/162 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 101/139 |
| 2021 | MICROBIOLOGY | SCIE | Q3 | Q3 | 98/137 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 215/295 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q3 | 127/162 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 96/140 |
| 2020 | MICROBIOLOGY | SCIE | Q3 | Q3 | 97/136 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 205/297 |
| 2019 | IMMUNOLOGY | SCIE | Q3 | Q3 | 119/159 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 90/139 |
| 2019 | MICROBIOLOGY | SCIE | Q3 | Q3 | 90/136 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 208/299 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q3 | 126/158 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 85/136 |
| 2018 | MICROBIOLOGY | SCIE | Q3 | Q3 | 93/133 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 191/293 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q2 | 112/155 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q2 | 80/133 |
| 2017 | MICROBIOLOGY | SCIE | Q3 | Q2 | 75/126 |
| 2016 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 180/290 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 105/151 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 72/128 |
| 2016 | MICROBIOLOGY | SCIE | Q3 | — | 67/125 |
| 2015 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 134/289 |
| 2015 | IMMUNOLOGY | SCIE | Q2 | — | 75/151 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 50/124 |
| 2015 | MICROBIOLOGY | SCIE | Q2 | — | 51/123 |
| 2014 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 105/290 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 57/148 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 39/123 |
| 2014 | MICROBIOLOGY | SCIE | Q2 | — | 35/119 |
| 2013 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 177/291 |
| 2013 | IMMUNOLOGY | SCIE | Q3 | — | 83/144 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 55/124 |
| 2013 | MICROBIOLOGY | SCIE | Q2 | — | 57/119 |
| 2012 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 159/290 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 78/137 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 52/121 |
| 2012 | MICROBIOLOGY | SCIE | Q2 | — | 51/116 |
| 2011 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 81/290 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 37/139 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q1 | — | 23/112 |
| 2011 | MICROBIOLOGY | SCIE | Q1 | — | 26/114 |
| 2010 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | — | 117/286 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 52/134 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 29/106 |
| 2010 | MICROBIOLOGY | SCIE | Q2 | — | 31/107 |
| 2009 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | — | 177/283 |
| 2009 | IMMUNOLOGY | SCIE | Q3 | — | 87/128 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | — | 41/93 |
| 2009 | MICROBIOLOGY | SCIE | Q3 | — | 54/95 |
| 2008 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | — | — | — |
| 2008 | IMMUNOLOGY | SCIE | — | — | — |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | — | — | — |
| 2008 | MICROBIOLOGY | SCIE | — | — | — |